TNNI3 and neoplasm: Recently, we have identified a small molecule inhibitor of FOXM1 (Robert Costa Memorial Drug-1, RCM1) that has shown to be an effective anti-tumor agent and is also non-toxic in pre-clinical mouse models (19, 25).